Results 61 to 70 of about 1,494,935 (289)

The effect of smoking on residual platelet reactivity to clopidogrel: a systematic review and meta-analysis

open access: yesPlatelets, 2020
Cigarette smoking is an important cardiovascular risk factor, causing morbidity and mortality. There are many original studies on the impact of smoking, but its influence on platelet ADP-P2Y12 receptor inhibitors lack consistency.
Zhiyan Liu   +10 more
doaj   +1 more source

Intracerebral Hemorrhage Induces Monocyte TNF Signaling in Patients That Is Suppressed by BAF312

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Intracerebral hemorrhage (ICH) causes high morbidity and mortality, with neurotoxic inflammation driven by infiltrating monocytes. This study is an in‐depth longitudinal examination of the immune response during the first week of ICH in the presence and absence of the immunomodulatory drug BAF312 (Siponimod).
Jonathan Howard DeLong   +10 more
wiley   +1 more source

A New Shear-Stress-Based Point-of-Care Technology for Evaluation of the Hemostatic Pattern in Whole Blood

open access: yesBiosensors
The currently available point-of-care hemostasis tests are burdened by criticisms concerning the use of different activators and inhibitors and the lack of dynamic flow.
Alessandro Foladore   +8 more
doaj   +1 more source

Efeito inibitório duradouro do óxido nítrico sobre a agregação plaquetária [PDF]

open access: yes, 2012
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências Biológicas. Programa de Pós-Graduação em FarmacologiaA agregação plaquetária ocorre fisiologicamente para ocluir lesões em vasos ou em condições anormais como na ...
Gonçalves, Muryel de Carvalho
core  

Anticoagulation Treatment Response Among Phenotypic ESUS Clusters: Evidence From CASPR

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate treatment effect heterogeneity across phenotypic clusters of patients with cryptogenic embolic stroke using causal inference methods. Methods From a retrospective, multicenter cohort of patients with cryptogenic embolic stroke, we estimated the treatment effect of anticoagulation versus antiplatelet therapy in patients ...
Elena Badillo Goicoechea   +53 more
wiley   +1 more source

Platelet aggregation during targeted temperature management after out-of-hospital cardiac arrest: A randomised clinical trial

open access: yesPlatelets, 2018
Some studies conclude that mild hypothermia causes platelet dysfunction leading to an increased bleeding risk, whereas others state that platelet aggregation is enhanced during mild hypothermia.
Anni Nørgaard Jeppesen   +5 more
doaj   +1 more source

Neutrophil extracellular traps induce aggregation of washed human platelets independently of extracellular DNA and histones

open access: yesCell Communication and Signaling, 2018
Background The release of neutrophil extracellular traps (NETs), a mesh of DNA, histones and neutrophil proteases from neutrophils, was first demonstrated as a host defence against pathogens.
Omar Elaskalani   +2 more
doaj   +1 more source

Exogenous Inhibitors of Platelet Aggregation from Animal Sources

open access: yes, 2001
SummaryThis updated inventory includes all inhibitors of platelet aggregation from animal sources until mid-1999. They are proteins or glycoproteins with Mr from 5000 to tens of thousands, and inhibit platelet aggregation by different mechanisms.
Geraldine Chow, R. Manjunatha Kini
core   +1 more source

Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT?

open access: yesBlood Advances, 2019
: Activation of the platelet Fc-receptor CD32a (FcγRIIA) is an early and crucial step in the pathogenesis of heparin-induced thrombocytopenia type II (HIT) that has not been therapeutically targeted.
Luise Goldmann   +8 more
doaj   +1 more source

Drug interactions and hepatotoxicity of clopidogrel [PDF]

open access: yes, 2010
Clopidogrel (Plavix¨) is an antiplatelet drug, which is clinically used in combination with aspirin to reduce cardiovascular events in patients undergoing percutaneous coronary intervention or in patients suffering from acute coronary syndromes ...
Zahno, Anja-Christina
core   +1 more source

Home - About - Disclaimer - Privacy